top of page


FDA Approved: New Long-Acting PrEP Regimen and Its Implications
In June 2025, the US Food and Drug Administration approved a new HIV pre-exposure prophylaxis (PrEP) regimen: the long-acting injectable...
Jun 2330 min read


Building Global Power: A National Strategy for Deeptech Health Startups in Brazil
The emergence of cutting-edge technologies, known as deeptechs, marks a new phase in global innovation. These technologies, which emerge...
Jun 633 min read


Only 10% of Brazilian Invention Patents Originate in Brazil: What Does This Mean for Our Sovereignty?
Technological innovation is a fundamental factor for a country’s economic development and competitiveness. In Brazil, intellectual...
Mar 94 min read


Exploring the Potential of Brazilian Biodiversity in Health
Brazil’s biodiversity, widely recognized as one of the richest in the world, offers a window of opportunity for innovative health...
Jan 264 min read


The Importance of Regulatory Agencies in Health Innovation and Pharmaceutical Regulation: FDA, EMA, and ANVISA in Perspective
Health innovation and the remarkable growth of the pharmaceutical sector—with a projected global revenue of USD 1.155 trillion in...
Nov 1, 20244 min read
bottom of page
